Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Nov;140 Suppl(Suppl 1):S63-72.

RISUG: an intravasal injectable male contraceptive

N K Lohiya  1 , I Alam, M Hussain, S R Khan, A S Ansari
Affiliations
Review

RISUG: an intravasal injectable male contraceptive

N K Lohiya et al. Indian J Med Res. 2014 Nov.

Abstract

Over the last two decades RISUG has been drawing attention in the field of male contraception. It promises to sterile men for a period of up to 10-15 years. According to recent studies in animal models, it proves to be completely reversible. Practically, there are no better options available that can assure complete sterility and precise reversibility. Regardless of so much of information available, RISUG is still holding up for many reasons, firstly, the available information engender bewilderment such as what is this copolymer, how does it work and is reversal really possible? Secondly, advancement of this outstanding invention is drastically slow and thirdly, effects of long-term contraception with RISUG and reports on evaluation of anomalies (if any) in F 1 , F 2 progenies, are lacking. In this review the lacunae as well as advances in the development of RISUG in the light of published work and available resources are pointed out. Formulation of the RISUG, its mode of action and clinical trials have been addressed with particular emphasis.

PubMed Disclaimer

Figures

Fig
Fig
Diagrammatic representation of reactive oxygen species (ROS) and total antioxidant capacity (TAC) localization in human sperm. SOD, superoxide dismutase.
See this image and copyright information in PMC

References

    1. Misro MM, Guha SK, Singh H, Mahajan S, Ray AR, Vasudevan P. Injectable non-occlusive chemical contraception in the male-I. Contraception. 1979;20:467–73. - PubMed
    1. Verma K, Misro MM, Singh H, Mahajan S, Ray AR, Guha SK. Histology of the rat vas deferens after injection of a non-occlusive chemical contraceptive. J Reprod Fertil. 1981;63:539–42. - PubMed
    1. Sethi N, Srivastava RK, Singh RK, Bhatia GS, Sinha N. Chronic toxicity of styrene maleic anhydride, a male contraceptive, in rhesus monkeys (Macaca mulatta) Contraception. 1990;42:337–47. - PubMed
    1. Sethi N, Srivastava RK, Singh RK. Histological changes in the vas deferens of rats after injection of a new male antifertility agent ‘SMA’ and its reversibility. Contraception. 1990;41:333–9. - PubMed
    1. Lohiya NK, Suthar R, Khandelwal A, Goyal S, Ansari AS, Manivannan B. Sperm characteristics and teratology in rats following vas occlusion with RISUG ® and its reversal. Int J Androl. 2010;33:e198–206. - PubMed

Publication types